YONG KO: Open Payments
NPI 1285247437 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 31 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $200 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
Products named: SPRAVATO, CAPLYTA, INVEGA SUSTENNA, INGREZZA, REXULTI, VRAYLAR, Auvelity, Quviviq.
Industry payments across FL — which companies pay providers there.
